Plant Leading Medical Research; AMERSHAM: Chief Executive of Global Concern Renames Premises
Byline: WILL SMALE Assistant Business Editor
THE chief executive of health science group Amersham has praised the work of its Cardiff facility, saying the plant is helping it lead the way in finding the medicines of the future.
Sir William Castell visited the site in Whitchurch yesterday, to officially rename the centre.
Previously called Cardiff Laboratories, it has become The Maynard Centre, in honour of Dr John Maynard, who was instrumental in establishing the company in Cardiff in the late 1970s.
Now employing 500 people, the centre conducts both manufacturing and research and development for the company.
The centre's scientists continue to establish themselves as world leaders in cell biology research.
In conjunction with the company's overall genetics work, their studies continue to aid the development of the next generation of medicines and treatments.
These include using a fluorescent protein dye to target cancer cells, and drugs that can be specifically tailored for individual patients.
As a global concern that employs 9,500 people, Amersham's share of the lucrative US market is worth pounds 1bn alone.
Sir William said, "Our Cardiff operation is most definitely a vital part of our global operations. Our staff here really are leading the way in cell biology research.
"By better understanding the process of life, we are predicting and preventing diseases. That is what we are about - we are good at visualising life.
"The aim is to lead the improvement of medicines, and the creation of more personalised medicines with fewer side-effects."
In the past Amersham has attracted some criticism for its use of radioactive material, but like the now ubiquitous X-ray machine, it serves a vital medical purpose. …